Royal Bank of Canada’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.6M | Buy |
13,843
+565
| +4% | +$109K | ﹤0.01% | 2894 |
|
|
2025
Q4 | $2.51M | Sell |
13,278
-1,103
| -8% | -$204K | ﹤0.01% | 2959 |
|
|
2025
Q3 | $2.38M | Sell |
14,381
-4,621
| -24% | -$753K | ﹤0.01% | 3253 |
|
|
2025
Q2 | $2.91M | Buy |
19,002
+981
| +5% | +$146K | ﹤0.01% | 3010 |
|
|
2025
Q1 | $2.83M | Sell |
18,021
-730
| -4% | -$118K | ﹤0.01% | 2686 |
|
|
2024
Q4 | $2.94M | Sell |
18,751
-3,751
| -17% | -$631K | ﹤0.01% | 2735 |
|
|
2024
Q3 | $3.99M | Sell |
22,502
-8,050
| -26% | -$1.43M | ﹤0.01% | 2456 |
|
|
2024
Q2 | $5.14M | Buy |
30,552
+1,559
| +5% | +$255K | ﹤0.01% | 2158 |
|
|
2024
Q1 | $4.82M | Buy |
28,993
+2,479
| +9% | +$410K | ﹤0.01% | 2202 |
|
|
2023
Q4 | $4.38M | Buy |
26,514
+1,732
| +7% | +$267K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $3.86M | Sell |
24,782
-7,327
| -23% | -$1.17M | ﹤0.01% | 2299 |
|
|
2023
Q2 | $5.01M | Buy |
32,109
+601
| +2% | +$96K | ﹤0.01% | 2091 |
|
|
2023
Q1 | $5.11M | Buy |
31,508
+10,612
| +51% | +$1.72M | ﹤0.01% | 2052 |
|
|
2022
Q4 | $3.34M | Sell |
20,896
-5,245
| -20% | -$831K | ﹤0.01% | 2457 |
|
|
2022
Q3 | $3.68M | Sell |
26,141
-10,849
| -29% | -$1.64M | ﹤0.01% | 2326 |
|
|
2022
Q2 | $5.39M | Buy |
36,990
+6,195
| +20% | +$923K | ﹤0.01% | 2044 |
|
|
2022
Q1 | $4.99M | Sell |
30,795
-7,076
| -19% | -$1.15M | ﹤0.01% | 2270 |
|
|
2021
Q4 | $7.17M | Sell |
37,871
-9,351
| -20% | -$1.8M | ﹤0.01% | 2126 |
|
|
2021
Q3 | $9.55M | Sell |
47,222
-6,451
| -12% | -$1.35M | ﹤0.01% | 1849 |
|
|
2021
Q2 | $10.8M | Buy |
53,673
+1,691
| +3% | +$315K | ﹤0.01% | 1763 |
|
|
2021
Q1 | $9.12M | Sell |
51,982
-9,942
| -16% | -$1.8M | ﹤0.01% | 1821 |
|
|
2020
Q4 | $10.5M | Buy |
61,924
+2,299
| +4% | +$379K | ﹤0.01% | 1674 |
|
|
2020
Q3 | $9.66M | Sell |
59,625
-2,029
| -3% | -$330K | ﹤0.01% | 1567 |
|
|
2020
Q2 | $10M | Sell |
61,654
-2,898
| -4% | -$440K | ﹤0.01% | 1468 |
|
|
2020
Q1 | $8.26M | Buy |
64,552
+26,680
| +70% | +$3.59M | ﹤0.01% | 1479 |
|
|
2019
Q4 | $5.28M | Sell |
37,872
-6,260
| -14% | -$823K | ﹤0.01% | 2119 |
|
|
2019
Q3 | $5.21M | Buy |
44,132
+2,705
| +7% | +$336K | ﹤0.01% | 2047 |
|
|
2019
Q2 | $5.34M | Buy |
41,427
+9,175
| +28% | +$1.13M | ﹤0.01% | 2015 |
|
|
2019
Q1 | $4.14M | Sell |
32,252
-15,237
| -32% | -$1.92M | ﹤0.01% | 2153 |
|
|
2018
Q4 | $5.26M | Sell |
47,489
-30,181
| -39% | -$3.65M | ﹤0.01% | 1940 |
|
|
2018
Q3 | $10.6M | Buy |
77,670
+25,855
| +50% | +$3.36M | ﹤0.01% | 1589 |
|
|
2018
Q2 | $6.22M | Buy |
51,815
+2,088
| +4% | +$246K | ﹤0.01% | 1865 |
|
|
2018
Q1 | $5.99M | Sell |
49,727
-2,692
| -5% | -$338K | ﹤0.01% | 1880 |
|
|
2017
Q4 | $6.53M | Sell |
52,419
-7,585
| -13% | -$969K | ﹤0.01% | 1875 |
|
|
2017
Q3 | $8.05M | Sell |
60,004
-543
| -0.9% | -$70.7K | ﹤0.01% | 1682 |
|
|
2017
Q2 | $7.61M | Buy |
60,547
+2,863
| +5% | +$345K | ﹤0.01% | 1685 |
|
|
2017
Q1 | $6.87M | Sell |
57,684
-14,588
| -20% | -$1.71M | ﹤0.01% | 1708 |
|
|
2016
Q4 | $7.77M | Buy |
72,272
+32,721
| +83% | +$3.56M | ﹤0.01% | 1662 |
|
|
2016
Q3 | $4.56M | Sell |
39,551
-1,612
| -4% | -$184K | ﹤0.01% | 1977 |
|
|
2016
Q2 | $4.21M | Buy |
41,163
+2,165
| +6% | +$231K | ﹤0.01% | 2010 |
|
|
2016
Q1 | $4.04M | Buy |
38,998
+9,392
| +32% | +$980K | ﹤0.01% | 1956 |
|
|
2015
Q4 | $3.76M | Buy |
29,606
+1,415
| +5% | +$173K | ﹤0.01% | 2045 |
|
|
2015
Q3 | $3.22M | Buy |
28,191
+3,545
| +14% | +$469K | ﹤0.01% | 1872 |
|
|
2015
Q2 | $3.32M | Buy |
24,646
+6,784
| +38% | +$902K | ﹤0.01% | 1884 |
|
|
2015
Q1 | $2.31M | Sell |
17,862
-15,325
| -46% | -$1.93M | ﹤0.01% | 2157 |
|
|
2014
Q4 | $3.83M | Buy |
33,187
+13,400
| +68% | +$1.51M | ﹤0.01% | 1844 |
|
|
2014
Q3 | $2.09M | Buy |
19,787
+843
| +4% | +$85.3K | ﹤0.01% | 2267 |
|
|
2014
Q2 | $1.81M | Buy |
18,944
+2,410
| +15% | +$216K | ﹤0.01% | 2368 |
|
|
2014
Q1 | $1.5M | Sell |
16,534
-994
| -6% | -$96.6K | ﹤0.01% | 2456 |
|
|
2013
Q4 | $1.55M | Sell |
17,528
-171
| -1% | -$14.3K | ﹤0.01% | 2483 |
|
|
2013
Q3 | $1.47M | Buy |
17,699
+8,956
| +102% | +$703K | ﹤0.01% | 2437 |
|
|
2013
Q2 | $599K | Buy |
+8,743
| New | +$608K | ﹤0.01% | 2993 |
|
Other funds holding BBH
MIM
CCA
BFG
Royal Bank of Canada's BBH Position: Q1 2026 in Review
Royal Bank of Canada increased its VanEck Biotech ETF (BBH) stake by 4.3% in Q1 2026, buying an estimated $109K and bringing the position to 13,843 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2894.
Royal Bank of Canada first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.8M in Q2 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Royal Bank of Canada held 13,843 shares of VanEck Biotech ETF worth $2.6M as of Q1 2026.
- Royal Bank of Canada bought 565 VanEck Biotech ETF shares in Q1 2026, an estimated $109K.
- VanEck Biotech ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2894 holding.
- Royal Bank of Canada first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's VanEck Biotech ETF position peaked at $10.8M in Q2 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.